Goldman Sachs Group Inc Generation Bio Co. Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
Shares
22 transactions
Others Institutions Holding GBIO
# of Institutions
28Shares Held
11.4MCall Options Held
116KPut Options Held
0-
Black Rock Inc. New York, NY3.29MShares$17.9 Million0.0% of portfolio
-
Atlas Venture Life Science Advisors, LLC828KShares$4.49 Million1.14% of portfolio
-
Nuveen Asset Management, LLC Chicago, IL169KShares$917,4160.0% of portfolio
-
Kestra Private Wealth Services, LLC57KShares$308,9400.0% of portfolio
-
Abel Hall, LLC Baton Rouge, LA23.6KShares$127,7220.0% of portfolio
About Generation Bio Co.
- Ticker GBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,011,200
- Market Cap $320M
- Description
- Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...